SETDB1 and leukemia: The H3K9 methyltransferase SETDB1 has been reported to play a tumor suppressor role by limiting the expression of genes targeted by MLL1 fusion proteins (72), contraindicating SETDB1 inhibition in the treatment of MLLr leukemias.